Austedo XR 36 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FD8W9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,315
Award facts
- Contract value 100% obligated
- $53,315.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,315.12 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Austedo XR 36 mg tablets (30-count units). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 7, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains significant federal contracting relationships focused on supplying medications and medical supplies to defense and veteran healthcare systems. Austedo XR is a neurological treatment medication, consistent with the company's portfolio of specialty pharmaceuticals delivered through competitively awarded DLA contracts. The underlying IDC enables AmerisourceBergen to provide a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare customers globally.
Quick answers
Who was awarded contract SPE2DB25FD8W9?
SPE2DB25FD8W9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FD8W9 worth?
The government has obligated $53,315 on SPE2DB25FD8W9.
Is contract SPE2DB25FD8W9 an order under another contract?
Yes. SPE2DB25FD8W9 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD8W9 competed?
The extent of competition for SPE2DB25FD8W9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award